Pfizer will cut 500 jobs at its Sandwich, Kent site in the U.K. as part of its $3.5 billion cost-cutting plan, the drugmaker said on Tuesday. The U.S. drugmaker announced the cost-cutting program in October after slashing its full-year revenue forecast due to lower-than-expected sales of its COVID-19 vaccine and treatment. The demand slump also…
US drugmaker, Pfizer has announced that preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it. In a news release on Wednesday, December 8, Pfizer alongside BioNtech said samples from people who had two…
UK has approved the Pfizer/BioNTech COVID-19 vaccine for public use. It is the first country to gives its nod to the mass use of the vaccine. In November, Pfizer announced that it had developed a vaccine that could offer 95 percent protection against COVID-19. MHRA, the British health regulator, said the vaccine is safe for…
